Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T6741 mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy.
Ohnishi
Hiroaki
H
Kandabashi
Koji
K
Maeda
Yoshiharu
Y
Kawamura
Machiko
M
Watanabe
Takashi
T
D000328:Adult; D002908:Chronic Disease; D018450:Disease Progression; D004802:Eosinophilia / Q000150:complications / Q000188:drug therapy; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications / Q000188:drug therapy; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000150:complications / Q000235:genetics*; D008297:Male; D009154:Mutation; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics*
D015514:Oncogene Proteins, Fusion; D039221:mRNA Cleavage and Polyadenylation Factors; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha